SCHEDULE: Wellington Management Discloses 10.7% Stake in Heartflow

Wellington Management Group LLP and its affiliates have reported a beneficial ownership of 10.7% in Heartflow, Inc. common stock as of July 31, 2026.

Summary

• Wellington Management Group LLP, along with its affiliated entities, has filed a Schedule 13G, indicating a significant beneficial ownership of Heartflow, Inc. common stock.
• The filing, dated July 31, 2026, reports a total of 9,232,829 shares beneficially owned, representing approximately 10.7% of the class of securities.
• This filing is an amendment (Amendment No. 4) to a previous Schedule 13G.
• The reporting entities include Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP.
• These entities are classified as investment advisers (IA) or holding companies (HC) for reporting purposes.
• The shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant but not unexpected ownership stake by a major investment manager. The filing confirms a substantial holding without signaling aggressive acquisition or divestment.

Positives

• Confirms a substantial institutional investor (Wellington Management) holds a significant stake (10.7%) in Heartflow, Inc., which can signal confidence in the company's long-term prospects.
• The filing indicates the shares are held in the ordinary course of business, suggesting a stable, long-term investment rather than a short-term speculative play.

Negatives

• The filing does not provide specific details on the acquisition of these shares or any recent trading activity, limiting insight into current sentiment.
• The aggregate ownership is spread across multiple Wellington entities, which is standard for large asset managers but adds complexity to understanding direct control.

Risks

• While not explicitly stated as a risk in this filing, significant ownership by a single entity can lead to concentrated decision-making or potential future changes in investment strategy that could impact the stock.
• The filing is an amendment, suggesting prior filings and ongoing monitoring by Wellington, but does not detail any specific risks related to Heartflow's business operations.

Future Outlook

The filing itself does not contain forward-looking statements or specific guidance from Heartflow, Inc. It solely reports on the beneficial ownership of securities by Wellington Management entities.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that significant ownership filings by large asset managers like Wellington are common in the healthcare technology sector, reflecting active portfolio management and strategic allocation of capital. Heartflow operates in the medical device industry, specifically focusing on non-invasive diagnostic solutions for coronary artery disease.

Comparison to Industry Standards

• Wellington Management is a global investment management firm managing assets for institutional and retail clients. Their holdings are typically diversified across various sectors.
• A 10.7% stake in a publicly traded company is considered a significant minority position, often held by dedicated long-term investors or specialized funds.
• The filing does not provide specific comparable companies or projects for Heartflow, but Wellington's investment suggests it meets their criteria for potential growth within the medical technology space.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's confidence, potentially stabilizing or increasing investor interest. However, it does not directly alter shareholder rights or voting power beyond the standard rights associated with share ownership.
• Creditors: A stable, significant shareholder can be viewed positively, indicating a commitment to the company's ongoing operations and potential for long-term value creation.
• Employees: Continued investment by major financial institutions can support company growth initiatives, potentially leading to job security and expansion opportunities.

Next Steps

• Wellington Management will continue to monitor its investment in Heartflow, Inc.
• Future amendments to this Schedule 13G will be filed if there are material changes in beneficial ownership.

Key Dates

Recommendation

This filing is a routine disclosure of beneficial ownership by a major investment manager. It confirms a significant stake but does not provide new operational or financial information about Heartflow, Inc. that would warrant a buy or sell recommendation. The holding is consistent with typical institutional investment strategies and suggests a neutral stance pending further company-specific developments.

Keywords

Heartflow, Wellington Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Advisers, Holding Company